Clik here to view.
蓝十字蓝盾协会总裁兼首席执行官将在WIN2014研讨会上致开幕词
巴黎 (美国商业资讯)–WIN联合会(www.winconsortium.org)今日非常荣幸地宣布，蓝十字蓝盾协会(Blue Cross and Blue Shield Association, BCBSA)总裁兼首席执行官Scott P. Serota将在个体化抗癌医学领域中的WIN...
View ArticleClik here to view.
Clik here to view.
BioTime, Inc. Subsidiary OncoCyte Corporation Initiates Clinical Development...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both...
View ArticleClik here to view.
阿斯利康、DKFZ和EORTC加入WIN联合会
巴黎 (美国商业资讯)–世界个体化抗癌医学创新网络联合会（简称WIN联合会）自豪地宣布，阿斯利康、DKFZ和EORTC已加入联合会。WIN是由领先的学术机构、企业、支付方和患者权益组织构成的独特全球网络，旨在为世界各地患者实现精准抗癌治疗。WIN创始人兼首席运营官Vladimir...
View ArticleClik here to view.
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia
CAMBRIDGE, Mass. & MELBOURNE, Australia ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Specialised Therapeutics Australia Pty Ltd (STA), a specialty pharmaceutical company, today announced that...
View ArticleClik here to view.
Sosei Signs Distribution Agreement with FUJIFILM Pharma for Commercialization...
TOKYO Sosei Group Corporation (TOKYO:4565), the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., (“Sosei K.K.”) has signed a distribution agreement for...
View ArticleClik here to view.
ArQule Announces Commencement of Phase 3 Clinical Trial with Tivantinib in...
WOBURN, Mass. ArQule, Inc. (Nasdaq: ARQL) today reported the announcement by its partner, Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151) of the initiation of a Phase 3 clinical trial evaluating...
View ArticleClik here to view.
Verastem社のmTORC1/2及びPI3K低分子二重阻害薬VS-5584に日本の特許が承認される
米国マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — がん幹細胞を標的とした抗癌剤の開発を行っている Verastem 社（NASDAQ; VSTM）は、日本の特許庁から同社の mTORC1/2 及び PI3K 低分子二重阻害薬であるVS-5584に特許が付与された事を本日公表した。当該特許は「キナーゼ阻害剤としてのピリミジン置換プリン化合物 」 ( Pyrimidine...
View ArticleClik here to view.
BSD Medical Announces Taiwan Food and Drug Administration Marketing and...
SALT LAKE CITY BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that...
View ArticleClik here to view.
ドバイ・エアポーツが空港タワーに描かれた巨大ながん啓発リボンを公開
Smart Multimedia Gallery The world’s largest cancer awareness ribbon on an air traffic control tower at Dubai International. (Photo: Business Wire) View and Share Photo Download Small アラブ首長国連邦ドバイ...
View ArticleClik here to view.
Novogene Acquires an Illumina HiSeq X Ten Sequencing System
SAN DIEGO Illumina, Inc. (NASDAQ:ILMN) today announced that Novogene (www.novogene.cn), a leading genomics service provider based in Beijing, China, purchased one HiSeq X Ten. This strategic...
View ArticleClik here to view.
AVEO and Astellas to End Worldwide Collaboration & License Agreement for...
CAMBRIDGE, Mass. & TOKYO AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced the companies will end their worldwide collaboration and license agreement for the...
View ArticleClik here to view.
BioAlliance Pharma SA: Strengthening and extension of the industrial...
PARIS Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), an innovative Company dedicated to the development of orphan oncology products, announced today a major strengthening...
View ArticleClik here to view.
パスウェイ・ゲノミクスが遺伝性大腸がん遺伝子検査を開始
サンディエゴ （ビジネスワイヤ） — 米サンディエゴに拠点を置き、CLIAおよびCAPの認定を受けて遺伝子検査サービスを世界規模で提供している臨床ラボラトリーのパスウェイ・ゲノミクス・コーポレーションは本日、当社の優良遺伝性がん遺伝子検査サービス「遺伝性大腸がんDNAインサイト（Hereditary Colorectal Cancer DNA...
View ArticleClik here to view.
Pathway Genomics上市遗传性结直肠癌基因检测
圣迭戈 (美国商业资讯)–Pathway Genomics Corporation是经过CLIA和CAP认证的临床实验室，总部位于圣迭戈，为全球提供基因检测服务，该公司今天宣布上市遗传性结直肠癌DNA InsightSM，这是该公司的首款遗传性癌症基因检测。该检测采用下一代测序(NGS)技术，只需一份简单的唾液样本，即可检出基因变化或突变，这些变化或突变可增高患者罹患某些类型癌症的风险。...
View ArticleClik here to view.
WIN联盟任命Winston and Strawn LLP为官方法律顾问
巴黎 (美国商业资讯)–个体化抗癌医学世界创新网络(WIN)联盟(www.winconsortium.org)荣幸地宣布，已经任命Winston and Strawn LLP...
View ArticleClik here to view.
Clik here to view.
The 13th Annual International Bioethics Forum Topic Announced: 3.8 Billion...
MADISON, Wis. Join scientists, writers, healers and other global experts in examining the almost infinite ways that nature expresses itself in plants, animals, microbes, fungi—across the spectrum of...
View ArticleClik here to view.
BSD Medical Announces Taiwan Food and Drug Administration Marketing Approval...
SALT LAKE CITY BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that...
View ArticleClik here to view.
Pathway Genomics下一代测序系统Illumina MiSeqDx获 FDA认证
圣迭戈 （美国商业资讯） — Pathway Genomics公司位于圣迭戈 ，是一家获 CLIA和 CAP认证的临床实验室，可为全球提供基因测试服务。Pathway Genomics今天宣布 Illumina MiSeqDx正式成为其下一代测序系统的一员。 通过对临床市场的设计和验证，该台式测序系统将优化公司在开发和诊断应用方面的能力。该系统...
View Article